Modern IVF treatment can now achieve substantially higher success rates than historical approaches while dramatically ...

In 2025, the overall U.S. death rate was down 4.6% from 2024, according to a July Vital Statistics Rapid Release report, a ...

A molecule linked to chronic inflammation disrupts the brain's ability to create new neurons, uncovering a pathway with ...

A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are ...

A new cancer drug may be able to inhibit both tumor growth and the spread of aggressive prostate cancer. This is shown in a ...

One in three men will experience moderate to severe lower urinary tract symptoms in their lifetime, with symptoms including ...

Researchers from UC Davis Medical Center have identified significant socioeconomic disparities among patients seeking ...

A collaborative research team has identified a novel blood-based biomarker capable of detecting early-stage lung cancer and ...

The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).

New research presented at the Federation of European Neuroscience Societies (FENS) Forum 2026 has discovered some of the ...

Early menopause affects 1 in 14 women ages 30 to 49 living in low- and middle-income countries, according to a pooled data ...

Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and ...